Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Colon cancer stem cells--from basic to clinical application.

Botchkina G.

Cancer Lett. 2013 Sep 10;338(1):127-40. doi: 10.1016/j.canlet.2012.04.006. Epub 2012 Apr 23. Review.

PMID:
22537805
2.

Colon cancer stem cells: controversies and perspectives.

Puglisi MA, Tesori V, Lattanzi W, Gasbarrini GB, Gasbarrini A.

World J Gastroenterol. 2013 May 28;19(20):2997-3006. doi: 10.3748/wjg.v19.i20.2997. Review.

3.

Colon cancer: cancer stem cells markers, drug resistance and treatment.

Kozovska Z, Gabrisova V, Kucerova L.

Biomed Pharmacother. 2014 Oct;68(8):911-6. doi: 10.1016/j.biopha.2014.10.019. Epub 2014 Oct 30. Review.

PMID:
25458789
4.

Can lung cancer stem cells be targeted for therapies?

Wu X, Chen H, Wang X.

Cancer Treat Rev. 2012 Oct;38(6):580-8. doi: 10.1016/j.ctrv.2012.02.013. Epub 2012 Mar 19. Review.

PMID:
22436486
5.

Stem cells in breast tumours: are they ready for the clinic?

Ablett MP, Singh JK, Clarke RB.

Eur J Cancer. 2012 Sep;48(14):2104-16. doi: 10.1016/j.ejca.2012.03.019. Epub 2012 Apr 26. Review.

PMID:
22542086
6.

Cancer stem cells: a new framework for the design of tumor therapies.

Garvalov BK, Acker T.

J Mol Med (Berl). 2011 Feb;89(2):95-107. doi: 10.1007/s00109-010-0685-3. Epub 2010 Oct 2. Review.

PMID:
20890588
7.

Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.

Ahmed N, Abubaker K, Findlay J, Quinn M.

J Cell Biochem. 2013 Jan;114(1):21-34. doi: 10.1002/jcb.24317. Review.

PMID:
22887554
8.

Colon cancer stem cells: promise of targeted therapy.

Todaro M, Francipane MG, Medema JP, Stassi G.

Gastroenterology. 2010 Jun;138(6):2151-62. doi: 10.1053/j.gastro.2009.12.063. Review.

PMID:
20420952
9.

Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.

Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z.

Oncogene. 2012 Feb 9;31(6):671-82. doi: 10.1038/onc.2011.282. Epub 2011 Jul 11.

PMID:
21743497
10.

Colorectal cancer stem cells.

Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG.

Stem Cells. 2012 Mar;30(3):363-71. doi: 10.1002/stem.1031. Review.

11.

LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.

Kobayashi S, Yamada-Okabe H, Suzuki M, Natori O, Kato A, Matsubara K, Jau Chen Y, Yamazaki M, Funahashi S, Yoshida K, Hashimoto E, Watanabe Y, Mutoh H, Ashihara M, Kato C, Watanabe T, Yoshikubo T, Tamaoki N, Ochiya T, Kuroda M, Levine AJ, Yamazaki T.

Stem Cells. 2012 Dec;30(12):2631-44. doi: 10.1002/stem.1257.

12.

Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.

Shigdar S, Lin J, Li Y, Yang CJ, Wei M, Zhus Y, Liu H, Duan W.

Ther Deliv. 2012 Feb;3(2):227-44. Review.

PMID:
22834199
13.

A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.

Ke J, Wu X, Wu X, He X, Lian L, Zou Y, He X, Wang H, Luo Y, Wang L, Lan P.

Neoplasma. 2012;59(3):282-8. doi: 10.4149/neo_2012_036.

PMID:
22329848
14.

Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.

Van Houdt WJ, Emmink BL, Pham TV, Piersma SR, Verheem A, Vries RG, Fratantoni SA, Pronk A, Clevers H, Borel Rinkes IH, Jimenez CR, Kranenburg O.

Mol Cell Proteomics. 2011 Dec;10(12):M111.011353. doi: 10.1074/mcp.M111.011353. Epub 2011 Jul 25.

15.

Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.

Serrano D, Bleau AM, Fernandez-Garcia I, Fernandez-Marcelo T, Iniesta P, Ortiz-de-Solorzano C, Calvo A.

Mol Cancer. 2011 Aug 9;10:96. doi: 10.1186/1476-4598-10-96.

16.

Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM.

J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. Review.

PMID:
18539958
17.

EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis.

Feng Y, Dai X, Li X, Wang H, Liu J, Zhang J, Du Y, Xia L.

Cell Prolif. 2012 Oct;45(5):413-9. doi: 10.1111/j.1365-2184.2012.00837.x.

PMID:
22925500
18.

Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

PMID:
22430355
19.

Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.

Zhu C, Cheng KW, Ouyang N, Huang L, Sun Y, Constantinides P, Rigas B.

Stem Cells. 2012 Oct;30(10):2065-75. doi: 10.1002/stem.1139.

20.

Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells.

Qiu M, Peng Q, Jiang I, Carroll C, Han G, Rymer I, Lippincott J, Zachwieja J, Gajiwala K, Kraynov E, Thibault S, Stone D, Gao Y, Sofia S, Gallo J, Li G, Yang J, Li K, Wei P.

Cancer Lett. 2013 Jan 28;328(2):261-70. doi: 10.1016/j.canlet.2012.09.023. Epub 2012 Oct 3.

PMID:
23041621

Supplemental Content

Support Center